Sex ‐related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: Results from the PROMETHEUS study
ConclusionWomen ≤ 55 years of age undergoing ACS PCI have significantly greater comorbidities than young men. Despite a higher risk clinical phenotype in women, prasugrel use was significantly lower in women than men. Female sex was associated with a significantly higher risk of 1‐year MACE and bleeding than male sex, findings that are attributable to baseline differences. © 2016 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - Category: Cardiovascular & Thoracic Surgery Authors: Jaya Chandrasekhar, Usman Baber, Samantha Sartori, Michela Faggioni, Melissa Aquino, Annapoorna Kini, William Weintraub, Sunil Rao, Samir Kapadia, Sandra Weiss, Craig Strauss, Catalin Toma, Brent Muhlestein, Anthony DeFranco, Mark Effron, Stuart Keller, B Tags: Coronary Artery Disease Source Type: research
More News: Angioplasty | Bleeding | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Chronic Kidney Disease | Clopidogrel | Coronary Angioplasty | Diabetes | Endocrinology | Heart | Heart Attack | Percutaneous Coronary Intervention | Plavix | Stroke | Study | Urology & Nephrology | Women